TeacherMitra.com
Dictionary
Dictionary
allow_url_fopen is ENABLED
Dictionary Search
Go Find!
dosed
Synonyms
Adjective
1. treated
Usage
Nasal MS therapy moves closer to results after final patient dosed - Multiple Sclerosis News Today
First Huntington’s Disease Patient Dosed with Neural Stem Cell Therapy - Inside Precision Medicine
California man dosed sons daily with hallucinogens, ran psilocybin operation - KTLA
SoCal man dosed his kids with hallucinogenic mushrooms every day - Los Angeles Times
California father pleads guilty to dosing children with psychedelic mushrooms, federal prosecutors say - Courthouse News
First patient dosed in Racura’s HARNESS-1 trial of RC220 - Clinical Trials Arena
REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone - Yahoo Finance
Dad Dosed Sons, Aged 9 and 11, with Hallucinogenic Mushrooms That He Made Them Help Grow - People.com
EyeWorld Weekly, June 26, 2026 - EyeWorld
Fallbrook father pleads guilty after dosing his kids with hallucinogenic mushrooms, selling them - fox5sandiego.com
First participant dosed in pioneering neural stem cell trial for Huntington’s disease - HDBuzz
California man admits to dosing his pre-teen children with psilocybin mushrooms - The Mercury News
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis - Ophthalmology Times
San Diego County father admits dosing young sons with hallucinogens daily - SFGATE
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis - Neurology® Journals
First patient dosed in Axsome’s FOCUS-3 trial of solriamfetol for ADHD - Yahoo
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board - PR Newswire
San Diego man pleads guilty to dosing his kids with ‘magic mushrooms’ - New York Post
First Huntington’s patient dosed in large trial of oral therapy votoplam - huntingtonsdiseasenews.com
Dosed - Dosed | OFFICIAL TRAILER [HD] - IMDb
AriBio completes main phase 3 dosing for oral Alzheimer's drug AR1001, topline data due this fall - koreabiomed.com
First Patient Dosed with Azenosertib in Aspenova Phase III Trial for Treatment of Ovarian Cancer - Applied Clinical Trials Online
First human dosed with cellular reprogramming drug in longevity trial - Washington Times
First patient dosed in CatalYm’s Phase IIb visugromab trial - Clinical Trials Arena
CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease - CytoDyn Inc.
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder - Morningstar
Dad Dosed Sons, Aged 9 and 11, with Hallucinogenic Mushrooms That He Made Them Help Grow - AOL.com
Quetzal Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire
Verrica Pharmaceuticals Announces First U.S. Patient Dosed - GlobeNewswire
First patient dosed in Merck’s Phase III PROCEADE-CRC-03 trial for mCRC - Clinical Trials Arena
AvenCell Therapeutics Announces First Patient Dosed in Phase I QUADvance Study with AVC-203, a Novel Allogeneic CD19/CD20 Dual-Targeting CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-Cell Malignancies - PR Newswire
CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer - CytoDyn Inc.
Dad Admits Dosing Kids Daily With Hallucinogenic Mushrooms - Newser
California dad admits dosing his children hallucinogenic mushrooms every other day - The Independent
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction - BioSpace
First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy - Ophthalmology Times
Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus - Ventus Therapeutics
First patient dosed in Newleos’ Phase Ib trial of NTX-2001 - Clinical Trials Arena
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera - Business Wire
Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma - Yahoo Finance
GEMMABio Announces First Patient Dosed in CHARISMA Trial of GB221, Investigational Next‑Generation Gene Therapy for Spinal Muscular Atrophy Type 1 (SMA1) - PR Newswire
Russian group hacked Quebec water treatment plant, gained access to control pumps and chlorine dosing: CSE - Yahoo News Canada
Unravel Biosciences Announces First Patient Dosed in RVL-001 Proof of Concept Studies for Rett Syndrome and Pitt Hopkins Syndrome - Business Wire
FibroBiologics Announces First Patients Dosed in Phase 1/2 - GlobeNewswire
First participant dosed in Jade’s Phase II JUNIPER trial for IgAN - Clinical Trials Arena
GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes - PR Newswire
First Patient Dosed in JANX014 Trial in Metastatic CRPC - Targeted Oncology
First patient dosed with CRISPR HBV silencer - CRISPR Medicine News
Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors - PR Newswire
First boys dosed in Phase 2 trial of oral DMD treatment SAT-3247 - Muscular Dystrophy News
First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer - Targeted Oncology
Atom Therapeutics Announces First Patient Dosed in China Phase 3 Clinical Trial of Lingdolinurad (ABP-671) for Chronic Gout - Business Wire
Iterion Therapeutics Expands Clinical Development of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, into Colorectal Cancer with First Patient Dosed - PR Newswire
Elevar Therapeutics Announces First Patients Dosed in Phase - GlobeNewswire
Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies - Yahoo Finance
GT Biopharma Announces First Patient Dosed in Phase 1 Trial - GlobeNewswire
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome - Biogen
Sapu Nano Announces First Patient Dosed in Phase 1b Trial - GlobeNewswire
AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab - PR Newswire
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial - GlobeNewswire
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advanced Solid Tumors - Business Wire
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study - PR Newswire
Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, in Relapsed/Refractory Osteosarcoma - PR Newswire
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer - PR Newswire
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder - Business Wire
First participants dosed in new POINT-HD huntingtin-lowering trial - HDBuzz
Alkeus Pharmaceuticals Announces First Patient Dosed in - GlobeNewswire
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE - GlobeNewswire
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - BioSpace
GE HealthCare: First Patient Dosed in Trial for Manganese-based MRI Contrast Agent - Imaging Technology News
NRG Therapeutics Announces First Participants Dosed in its - GlobeNewswire
Ukko Announces First Participant Dosed in Phase 1/2a Clinical Study Evaluating UKK-0018 for Peanut Allergy Treatment - BioSpace
GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder - PR Newswire
Milestone Alert: First Patient Dosed in Phase 3 Trial of Orelabrutinib for SLE - The Dermatology Digest
First Patient Dosed in New Study Investigating Novel Made-In-Canada Drug Candidate to Prevent Brain Injury in Hemodialysis Patients - Business Wire
Hinge Bio Announces First Subject Dosed in Phase 1 Trial of - GlobeNewswire
EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial - GlobeNewswire
Zentalis Pharmaceuticals Announces First Patient Dosed in - GlobeNewswire
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) - BioSpace
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites - PR Newswire
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004 - Fierce Biotech
Aplagon Announces First Patient Dosed in Phase 2a Clinical - GlobeNewswire
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-A - Yahoo Finance
Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies - Yahoo Finance
GlycoNex Announces Last Patient Dosed in Phase 3 Trial of SPD8, a Denosumab Biosimilar for Osteoporosis - PR Newswire
Kali Therapeutics Announces First Patient Dosed in Phase 1a Clinical Trial of KT501 for Rheumatoid Arthritis - BioSpace
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer - Business Wire
Development and validation of a machine learning model for individualised meropenem dosing in CRRT patients - Nature
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies - GlobeNewswire
Neomorph Announces First Patient Dosed in Phase 1/2 Trial - GlobeNewswire
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents - Business Wire
Qurient Announces First Patient Dosed in Phase 2 Trial of Novel CDK7 Inhibitor Mocaciclib (Q901) for the treatment of HR-Positive Breast Cancer - Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034 - Business Wire
First Participant Dosed in AskBio Phase 1/Phase 2 Gene - GlobeNewswire
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001 - BioSpace
HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis - Business Wire
daptomycin dosing antibiotics Critical Care Congress SCCM 2026 - Infectious Disease Special Edition
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas - PR Newswire
Biotheryx Announces First Patient Dosed in the Dose Expansion Phase of BTX-9341-101 for the Treatment of HR+/HER2- Breast Cancer - PR Newswire
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity - Yahoo Finance
Foreign Language Equivalents
Foreign Language Equivalents of 'dosed'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
dised, odsed, dosef, dosd, dsoed, doaed, doesd, dossed, doswd, dpsed, doseed, osed, dose, fosed, doded, dsed, doed, dosrd, sosed, doses, ddosed, dosde, doosed, dosedd
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z